17
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Pathology of hepatocellular carcinoma and its precursors using proton magnetic resonance spectroscopy and a statistical classification strategy

, , , , , , & show all
Pages 417-422 | Published online: 06 Jul 2009

  • Simonetti RG, Camma C, Fiorello F, Poliri F, d'Amico G, Pagliaro L. Hepatocellular carcinoma. A worldwide problem and the major risk factors. Dig Dis Sci 1991; 36: 962-72.
  • Duvoux C. Epidemiology and diagnosis of hepatocellular carcinoma in cirrhosis. Ann Chir 1998; 52: 511-7.
  • Sakamoto M, Hirohashi S, Shimosato Y. Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocel-lular carcinoma. Him Pathol 1991; 22: 172-8.
  • Nagato Y, Kondo F, Kondon Y, Ebara M, Ohto M. Histologie and morphometrical indicators for a biopsy diagnosis of well-differentiated hepatocellular carcinoma. Hepatology 1991; 14: 473-8.
  • Himmelreich U, Dzendrowskyj T, Alien C, et al. Cryptococcomas distinguished from gliomas with magnetic resonance spectroscopy: an experimental rat and cell culture study. Radiology 2001; 220: 122-8.
  • Russell P, Lean C, Delbridge L, May G, Dowd S, Mountford C. Proton magnetic resonance and human thyroid neoplasia. I: Discrimination between benign and malignant neoplasms. Am J Med 1994; 96: 383-8.
  • Hahn P, Smith I, Leboldus L, Littman C, Somorjai R, Bezabeh T. The classification of benign and malignant human prostate tissue by multivariate analysis of 1H magnetic resonance spectra. Cancer Res 1997; 57: 3398-401.
  • Rutter A, Hugenholtz H, Saunders J, Smith I. Classification of brain tumors by ex vivo 1H NMR spectroscopy. J Neural 1995; 64: 1655-61.
  • Mountford CE, Somorjai RL, Malycha P, et al. Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine needle aspirates analyzed using a statistical classification strategy. Br J Surg2001; 88: 1234-40.
  • Barry P, Wadstrom C, FaIk G, et al. What is the value of 1H MRS in detecting early malignant changes? In: Giuli R, editor. The oesophago-gastric junction. Montrouge: John Libbey Eurotext, 1998; 1122-7.
  • Somorjai R, Nikulin S, Pizzi N, et al. Computerized consensus diagnosis: a classification strategy for the robust analysis of MR spectra. I: Application to 1H spectra of thyroid neoplasms. Mag Res Med 1995; 33: 257-63.
  • Wallace J, Raaphorst G, Somorjai R, et al. Classification of 1H MR spectra of biopsies from untreated and recurrent ovarian cancer using linear discriminant analysis. Mag Res Med 1997; 38: 569-76.
  • Somorjai R, Dolenko B, Nikulin S, et al. Classification of 1H MR spectra of human brain biopsies: the influence of preprocessing and computerized consensus diagnosis on classification accuracy. J Mag Res Imaging 1996; 6: 437-44.
  • Lean C, Somorjai R, Smith ICP, Russell P, Mountford CE. Accurate diagnosis and prognosis of human cancers by proton MRS and a three stage classification strategy. In: Webb G, editor. Annual reports on NMR spectroscopy. Vol. 49. Orlando, FL: Academic Press, 2002 (in press).
  • Hagberg G. From magnetic resonance spectroscopy to classification of tumours. A review of pattern recognition methods. NMR Biomed 1998; 11: 148-56.
  • Homes E, Foxall PJD, Nicholson JK, et al. Automatic data reduction and pattern recognition methods for analysis of 1H nuclear magnetic resonance spectra of human urine from normal and pathological states. Anal Biochem 1994; 220: 284-96.
  • Homes E, Nicholls AW, Lindon JC, et al. Development of a model for classification of toxin-induced lesions using 1H NMR spectroscopy of urine combined with pattern recognition. NMR Biomed 1998; 11: 235-44.
  • Nikulin A, Dolenko B, Bezabeh T, Somorjai R. Near-optimal region selection for feature space reduction: novel preprocessing methods for classifying MR spectra, NMR Biomed 1998; 11: 209-17.
  • Somorjai R, Dolenko B, Nikulin A, Nickerson P, Rush D, Shaw A. Distinguishing normal from rejecting renal allografts: application of a three-stage classification strategy to MR and IR spectra of urine. Vibr Spectrosc 2002; 28: 97-102.
  • Efron B, Tibshirani R. An Introduction to the Bootstrap. Monographs of Statistics and Applied Probability. Vol. 57. New York: Chapman Hill, 1993.
  • Bubb WA, Wright LC, Cagney M, Santangelo RT, Sorrell TC, Kuchel PW. Heteronuclear NMR studies of metabolites produced by Crypto-coccus neoformans in culture media: Identification of possible virulence factors. Mag Res Med 1999; 42: 442-53.
  • Mackinnon W, Huschtscha L, Dent K, Hancock R, Paraskeva C, Mountford C. Correlation of cellular differentiation in human colorectal carcinoma and adenoma cell lines with metabolite profiles determined by 1H magnetic resonance spectroscopy. Int J Cancer 1994; 59: 248-61.
  • Hytiroglow P, Theise ND, Schwartz M, Mor E, Miller C, Thung SN. Macroregenerative nodules in a series of adult cirrhotic liver expiants: issue of classification and nomenclature. Hepatology 1995; 21:703-8.
  • Wanless I, Wanless IR, Mawdsley C, Adams R. On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 1985; 5:1194-200.
  • Scott FR, el-Rafaie A, More L, Scheuer PJ, Dhillon AP. HCC arising in an adenoma, value of Q band 10 (anti CD34) immunohistochemistry in the diagnosis of liver cell carcinoma. Histopathology 1996; 28: 472-4.
  • Nakamuma Y, Terada T, Ueda K, Terasaki S, Nomomura A, Matsui O. Adenomatous hyperplasia of the liver as a precancerous lesion. Liver 1993; 13: 1-9.
  • Borzio M, Bruno S, Roncalli M, et al. Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study. Gastroenterology 1995; 108: 812-7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.